Pfizer exits Haleon stake after $3.2B share sale

Pfizer (NYSE:PFE) has generated ??2.5B ($3.24B) after selling its entire stake in Haleon (NYSE:HLN), the consumer healthcare company it established with the British pharmaceutical giant GSK (GSK) in 2019, Reuters reported Wednesday, citing a bookrunner for the transaction.

The maker